EMBLA MEDICAL Stock Price, News & Analysis
Company Description
EMBLA MEDICAL (OTC Link: OSSUY) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $2.1B.
OSSUY stock has declined 6.5% over the past year. Shares last traded at $3.81.
This page provides a comprehensive overview of OSSUY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
EMBLA MEDICAL (OSSUY) stock last traded at $3.81. Over the past 12 months, the stock has lost 6.5%. At a market capitalization of $2.1B, OSSUY is classified as a mid-cap stock with approximately 427.8M shares outstanding.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in EMBLA MEDICAL (OSSUY) currently stands at 239 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 32.7%. This relatively low short interest suggests limited bearish sentiment. With 14.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for EMBLA MEDICAL (OSSUY) currently stands at 14.1 days, up 428.6% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 64.4% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
OSSUY Company Profile & Sector Positioning
EMBLA MEDICAL (OSSUY) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing OSSUY often look at related companies in the same sector, including Vitrolife (VTRLY), Gn Store (GNNDY), Getinge (GNGBY), Draegerwerk (DGWPF), and Kuros Bioscience (CSBTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OSSUY's relative position within its industry.